A great British story February 2018 1
Disc iscla laim imer This presentation has been prepared by National Milk Records plc ("the " Company ") and is for information purposes only. This presentation does not constitute an offering document or an offer of transferable securities to the public in the UK. This presentation is not intended to provide the basis for any credit or other evaluation of any securities of the Company and should not be considered as a recommendation, invitation or inducement that any investor should subscribe for, dispose of or purchase any such securities or enter into any other transaction with the Company or any other person. The merits and suitability of any investment action in relation to securities should be considered carefully and involve, among other things, an assessment of the legal, tax, accounting, regulatory, financial, credit and other related aspects of such securities. This presentation is not a financial promotion, and nor has it been approved as such, for the purposes of section 21 of the Financial Services and Markets Act 2000 (‘‘FSMA’’) . Reliance on the contents of this presentation for the purpose of engaging in any investment activity may expose you to a significant risk of losing all of the property or other assets invested. If you are in any doubt about the contents of this document or the action you should take, you are recommended to seek your own financial advice immediately from an appropriately authorised stockbroker, bank manager, solicitor, accountant or other independent financial adviser who, if you are taking advice in the United Kingdom, is duly authorised under the FSMA. This document may not be distributed, published, reproduced or otherwise made available to any other person, in whole or in part, for any purposes whatsoever. In particular, it should not be distributed to or otherwise made available to persons with addresses in Canada, Australia, Japan, the Republic of South Africa, the Republic of Ireland or the United States, its territories or possessions or in any other jurisdiction outside of the United Kingdom where such distribution or availability may lead to a breach of any law or regulatory requirements. The distribution of this document in other jurisdictions may be restricted by law, and persons into whose possession this document come should inform themselves about, and observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the laws of the relevant jurisdiction. All views expressed in this presentation are based on financial, economic, market and other conditions prevailing as of the date of this presentation. The Company does not undertake to provide access to any additional information or to update any future projections, management targets, estimates or assessment of future prospects or any other forward-looking statements to reflect events that occur or circumstances that arise after the date of this presentation, or to correct any inaccuracies in this presentation which may become apparent. Past performance is not indicative of future results and forward-looking statements are not guarantees of future performance. No representation or warranty (express or implied) of any nature is given nor is any responsibility or liability of any kind accepted by the Company or any of its directors, officers, employees, advisers, representatives or other agents, with respect to the truthfulness, completeness or accuracy of any information, projection, representation or warranty (expressed or implied), omissions, errors or misstatements in this presentation, or any other written or oral statement provided. In particular, no responsibility or liability is or will be accepted and no representation or warranty is or is authorised to be given as to the accuracy, reliability or reasonableness of any forward-looking statement, including any future projections, management targets, estimates or assessments of future prospects contained in this presentation, or of any assumption or estimate on the basis of which they have been given (which may be subject to significant business, economic or competitive uncertainties and contingencies beyond the control of the management of the Company). You should not place any reliance on forward-looking statements. Any such forward-looking statements have not been independently audited, examined or otherwise reviewed or verified and nothing in this presentation should be construed as a profit forecast. By accepting this document you will be taken to have warranted, represented and undertaken to the Company that: (a) you have read, agree to and will comply with the terms of this disclaimer; and (b) you will conduct your own analyses or other verification of the data set out in this document and will bear the responsibility for all or any costs incurred in doing so. You shall not use this presentation or the information contained herein in any manner detrimental to the Company. 2
An in introductio ion to NMR plc lc • Leading UK agri-business operating in the dairy and livestock data information services sector • Spun out of the Milk Marketing Board after its dissolution in 1997 • Supplies testing and analysis services along the supply chain to maximise the production and quality of milk • Yield • Health • Volume • Adulterants • Quality • Genomics • Hygiene • Exited the Milk Pension Fund in June 2017 • Clear, defined growth strategy • Strong and proven Board of Directors • Ability to grow in a recovering market 3
Operatin ing Se Sectors National Milk Records National Milk Laboratories Leading supplier of milk recording Provides payment and quality services to diary farms. Provides testing for major milk processors management information on a cow’s and retailers. performance. Nordic Star Independent Milk Laboratories GeneTracker Development business building service Joint Venture with Progressive Genomics testing to optimise provision in the red meat sector. Genetics based in Ireland. farmers herds and product. 4
Corp Co rporate Overvie iew Share Price Graph Major Shareholders 20% 29.70% 6.60% 10% 19.80% 13.90% Nex Exchange Ordinary shares in issue WCM LIC NMRP 21,239,702 Utilico Genus plc Share Price Market Cap. High Net Worths Other 92.5p (as of 20/02/18) £19.6 million (as of 20/02/18) 5
Recommend
More recommend
